Skip to main content
Clinical Trials/NCT02827734
NCT02827734
Unknown
Not Applicable

Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD)

Universitätsmedizin Mannheim1 site in 1 country50 target enrollmentOctober 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pulmonary Healthy Controls
Sponsor
Universitätsmedizin Mannheim
Enrollment
50
Locations
1
Primary Endpoint
airway resistance and reactance (R5, X5, R-D5-20) as determined by impulse oscillometry
Last Updated
6 years ago

Overview

Brief Summary

Current diagnostic tools used in interstitial lung disease (ILD) do not meet the challenges set by the complex pathophysiology of this heterogenous group. The investigators therefore aimed to evaluate novel or not widely used diagnostic approaches for the detection and therapeutic monitoring of patients with various ILDs.

Registry
clinicaltrials.gov
Start Date
October 2015
End Date
December 2020
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. Frederik Trinkmann

Principal Investigator

Universitätsmedizin Mannheim

Eligibility Criteria

Inclusion Criteria

  • known or suspected interstitial lung disease

Exclusion Criteria

  • pregnancy
  • inability to participate

Outcomes

Primary Outcomes

airway resistance and reactance (R5, X5, R-D5-20) as determined by impulse oscillometry

Time Frame: 30 minutes

lung clearance index (LCI) as determined by multiple breath washout

Time Frame: 30 minutes

Secondary Outcomes

  • repeatability of lung clearance index (LCI)(30 minutes)

Study Sites (1)

Loading locations...

Similar Trials